CATHERINE HEFNER: Open Payments
NPI 1336870187 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 83 payments from 27 companies in 2025. Trend: 2023 $1,781 · 2024 $1,693 · 2025 $1,654
Food & beverage: $1,604Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $303 |
| Lilly USA, LLC | 12 | $188 |
| BETA BIONICS, INC. | 4 | $95 |
| Amphastar Pharmaceuticals, Inc. | 4 | $90 |
| Madrigal Pharmaceuticals | 3 | $86 |
| Amgen Inc. | 5 | $86 |
| TOLMAR, INC. | 4 | $75 |
| Xeris Pharmaceuticals, Inc. | 5 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Chiesi USA, Inc. | 2 | $57 |
Products named: JARDIANCE, MOUNJARO, Ozempic, Rybelsus, iLet Bionic Pancreas, REZDIFFRA, TEPEZZA, JATENZO.
Industry payments across NC — which companies pay providers there.
